Febrivac 3 Plus
Febrivac 3 Plus
Authorised
- Clostridium botulinum, type C, toxoid
Product identification
Medicine name:
Febrivac 3 Plus
Active substance:
- Clostridium botulinum, type C, toxoid
Target species:
-
Mink
Route of administration:
-
Subcutaneous use
Product details
Active substance and strength:
-
Clostridium botulinum, type C, toxoid0.50/relative unit(s)1.00millilitre(s)
Pharmaceutical form:
-
Suspension for injection
Withdrawal period by route of administration:
-
Subcutaneous use
- Mink
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI20CL01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Germany
Package description:
- Available only in German
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
- IDT Biologika GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
- IDT Biologika GmbH
Responsible authority:
- Paul-Ehrlich-Institut
Authorisation number:
- 137a/92
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
German (PDF)
Published on: 29/03/2022
How useful was this page?:
